TikToker @erikamichelebeauty posted a brief update about her tirzepatide (Tirzepatide, brand name Zepbound) weight loss journey, mentioning she has "20-30lbs more to lose" and still wants a tummy tuck but feels "way better." The video got over 103,000 views and uses hashtags suggesting she's on a GLP-1 medication.
What does this video actually claim?
The creator makes minimal specific claims, mainly sharing that she's continuing her weight loss journey on tirzepatide and has 20-30 pounds left to lose. She mentions feeling better overall and still considering cosmetic surgery (tummy tuck) despite her progress.
The video is more of a personal update than a detailed testimonial about tirzepatide's effects. She doesn't make specific medical claims about the drug's efficacy or timeline. The hashtags #tirzep and #glp1 indicate she's using tirzepatide, which is accurate since tirzepatide is a GLP-1 receptor agonist.
The mention of still wanting a tummy tuck suggests she's dealing with loose skin or stubborn fat areas that weight loss medications don't address. This is a realistic expectation that matches how these drugs actually work.
Does the science support gradual weight loss with tirzepatide?
Yes, the clinical evidence strongly supports sustained weight loss with tirzepatide over extended periods. The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) showed participants lost an average of 22.5% of their body weight with the 15mg dose over 72 weeks.
The study found that weight loss typically plateaus around 60-72 weeks, which means people often have remaining weight to lose even after significant progress. In SURMOUNT-1, participants continued losing weight throughout the study period, but the rate slowed considerably after the first year.
Her comment about feeling "way better" also tracks with the data. The same trial reported improvements in physical functioning scores and quality of life measures. About 89% of participants on the highest dose achieved at least 5% weight loss, with many experiencing substantial improvements in energy and mobility.
What did she get right about cosmetic surgery expectations?
The creator's realistic expectation about still needing a tummy tuck shows she understands what weight loss medications can and can't do. Tirzepatide doesn't tighten loose skin or eliminate all stubborn fat deposits, particularly in the abdominal area.
Weight loss medications work by reducing appetite and slowing gastric emptying, leading to reduced caloric intake. They don't specifically target fat in particular body areas or address skin elasticity issues that develop after significant weight loss.
Many people who lose substantial amounts of weight (20+ pounds) develop loose skin that only surgical intervention can address. The creator's acknowledgment of this reality is more honest than many influencer posts that promise total body transformation through medication alone.
What should you know about ongoing tirzepatide treatment?
Tirzepatide requires long-term commitment and realistic expectations about timelines. The SURMOUNT-1 data shows most significant weight loss occurs in the first 60 weeks, with gradual continued progress afterward.
The medication starts at 2.5mg weekly and titrates up to a maximum of 15mg weekly over several months. Side effects like nausea and gastrointestinal issues are common, particularly during dose increases. The creator's positive mood suggests she's tolerating the medication well.
Cost remains a significant barrier, with Zepbound pricing around $1,000-$1,200 monthly without insurance coverage. Many insurance plans don't cover GLP-1 medications for weight loss, making long-term treatment financially challenging for most people. The creator doesn't address these practical considerations in her brief update.